Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy

Dermatologic Surgery

Volumn 36, Issue 5, 2010, Pages 652-658

  Willey, Andrea ^a,b,c,d   Mehta, Sheetal ^a,e   Lee, Peter K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Laser and Skin Surgery Center   (United States)

^c Solano Dermatology Associates   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; CETAPHIL; FLUOROURACIL; IMIQUIMOD; PETROLATUM; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BLUE LIGHT; CANCER INCIDENCE; CLINICAL ARTICLE; CRYOTHERAPY; CURETTAGE; DESQUAMATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; ERYTHEMA; FEMALE; FOCAL CRUSTING; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; TREATMENT DURATION;

ADULT; AGED; AMINOLEVULINIC ACID; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINNESOTA; ORGAN TRANSPLANTATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; PRIMARY PREVENTION; PROSPECTIVE STUDIES; RISK ASSESSMENT; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 77951293600     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01384.x     Document Type: Article

References (25)

1. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002 47 : 1 17.
2. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003 348 : 1681.
3. Ulrich C, Schmook T, Sachse M, et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004 30 : 622 627.
4. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004 4 : 905 913.
5. Ramsay HM, Reece SM, Fryere AA, et al. Seven-year prospective study of nonmelanoma skin cancer incidence in UK renal transplant recipients. Transplantation 2007 84 : 437 439.
6. Bordea C, Wojnarowska F, Millard PR, et al. Skin cancers in renal transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004 77 : 574.
7. Martinez JC, Otley CC, Stasko T, et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003 139 : 301 306.
8. Veness MJ, Quinn DI, Ong CS, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999 85 : 1758 1764.
9. Sheil AG, Disney AP, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 1993 25 : 1383 1384.
10. Euvrard S, Kanitakis J, Decullier E, et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006 81 : 1093 1100.
11. Bouwes Bavinck JN, Euvrard S, and The EPI-HPV-UV-CA Group. et al. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 2007 127 : 1647 1656.
12. Otley CC, Griffin MD, Charlton MR, et al. Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks. Br J Dermatol 2007 157 : 1183 1188.
13. Ulrich C, Kanitakis J, Stockfleth E, Euvard S. Skin cancer in organ transplant recipients - where do we stand today? Am J Transplant 2008 8 : 2192 2198.
14. Stasko T, Brown MD, Carucci JA, et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004 30 (4 Pt 2) : 623.
15. Ulrich C, Bichel J, Euvrard S, et al. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. Br J Dermatol 2007 157S2 : 25 31.
16. Perrett CM, McGregor JM, Warwick J, et al. Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol 2007 156 : 320 328.
17. De Graaf YG, Euvrard S, Bouwes Bavinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg 2004 30 (4 Pt 2) : 656 661.
18. Dragieva G, Hafner J, Dummer R, et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004 77 : 115 121.
19. Dragieva G, Prinz BM, Hafner J, et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004 151 : 196 200.
20. De Graaf YGL, Kennedy C, Wolterbeek R, et al. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organtransplant recipients: results of a randomizedcontrolled trial. J Invest Dermatol 2006 126 : 569 574.
21. Szemies RM, Karrer S, Sauerwald A, et al. Photodynamic therapy with topical delta-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology 1996 192 : 246 251.
22. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. Arch Dermatol 1997 133 : 727 732.
23. Markham T, Collins P. Topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol 2001 145 : 502 504. (Pubitemid 32953713)
24. Varma S, Wilson H, Kurwa HA, et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic photodynamic therapy using a large-field incoherent light source. Br J Dermatol 2001 144 : 567 574.
25. Oseroff A. PDT as a cytotoxic agent and biologic response modifier: implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. J Invest Dermatol 2006 126 : 542 544.